Breakthrough in Equine Grass Sickness research

There is encouraging news emerging from the Royal (Dick) School of Veterinary Studies, where researchers have identified what is believed to be the likely cause of Equine Grass Sickness (EGS) - a major development in our understanding of this devastating condition.

A probable cause identified

The research points to a neurotoxin as the probable causative agent in EGS. Specifically, investigators have identified an enzyme - phospholipase A2 - which is thought to be produced by microorganisms present in pasture.

Importantly, these microorganisms appear to proliferate under environmental conditions that are already recognised as risk factors for EGS, particularly:

• Cold, dry weather patterns

• Periods of environmental stress affecting pasture ecosystems

• 
  

This aligns with long-standing epidemiological observations, now underpinned by a plausible biological mechanism.

Why this matters

Equine Grass Sickness remains one of the most serious and often fatal conditions affecting grazing horses, characterised by dysfunction of the autonomic and enteric nervous systems.

Despite decades of research, progress in identifying a definitive cause has been limited = making this development particularly significant.

The identification of a likely neurotoxin opens several important avenues:

1. Improved diagnostics

A clearer understanding of the causative mechanism may enable the development of more accessible and earlier diagnostic tools, which has historically been a major challenge in EGS management.

2. Targeted therapeutics

With a defined biochemical pathway, there is potential to explore novel treatment strategies aimed at neutralising or mitigating the effects of the toxin.

3. Enhanced preventative strategies

Understanding how environmental and microbial factors interact may help refine risk management approaches, particularly during high-risk weather conditions.

A turning point in EGS research

For many within the equine and veterinary communities, progress in EGS research has often felt incremental. This discovery represents a meaningful shift.

As one researcher noted, “After years of feeling deflated by the lack of progress, it's wonderful to see this significant breakthrough.”

While further work is required to validate and expand upon these findings, the direction of travel is clear: a move towards mechanism-based understanding, diagnosis, and intervention.

Accessing the research

The full study has been published in the Equine Veterinary Journal and is available to read free of charge for a limited period. Read the paper here:

https://bit.ly/4f5McNQ

Looking ahead

This development marks an important step forward in tackling a condition that has long posed significant clinical and welfare challenges. Continued research will be critical, but the identification of a probable causative neurotoxin provides a clear and promising foundation for future advances.

Advancing understanding, improving outcomes, and supporting evidence-based equine care.